MeSH tree: C04.588.894.797
A new multi-site study, published in JAMA, and co-led by researchers at the UNC Lineberger Comprehensive Cancer Center and Wake Forest University School of Medicine, has demonstrated that a direct-to-patient digital health ...
Oct 20, 2025
0
15
The first-in-class YAP-TEAD inhibitor VT3989 continued to be well tolerated and demonstrated notable initial antitumor activity, particularly in patients with refractory mesothelioma, according to results from a trial led ...
Oct 19, 2025
0
20
New research published in Cell finds the existence of craters on the surface of melanoma cells that serve as immune hubs, becoming major sites for tumor killing. These craters could serve as good markers for immunotherapy ...
Oct 17, 2025
0
22
Researchers have developed a way to predict how lung cancer cells will respond to different therapies, allowing people with the most common form of lung cancer to receive more effective individualized treatment.
Oct 13, 2025
0
29
The Herpes simplex virus is a widespread virus that often causes cold sores, and most people carry it. By removing a virulence gene, i.e. a gene that makes the virus harmful to humans, the herpes virus can be repurposed as ...
Oct 1, 2025
0
17
University of Hawaiʻi Cancer Center researchers have identified a new, less aggressive form of mesothelioma that offers patients greater hope for survival and treatment success. Led by Michele Carbone and Haining Yang, the ...
Sep 30, 2025
0
21
A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC). Patients in the study ...
Sep 29, 2025
0
26
Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, chemotherapy, and immunotherapy. But a new discovery may change the way doctors approach treatment.
Sep 29, 2025
0
40
A new study led by researchers at the American Cancer Society (ACS) shows that the overall five-year cancer survival rates for each stage of cancer (localized, regional, distant) were lower in non-metropolitan areas for Black ...
Sep 25, 2025
0
23
About 5% of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, EML4 and ALK. This fusion results in different variants, and until now, clinicians have treated all ...
Sep 23, 2025
0
15
